iPS cells: A source of cardiac regeneration
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310 · cited 2×
“Human iPS cells were established in 2007, by the transduction of either the same set of transcription factors (c-Myc, Oct3/4, SOX2, Klf4) or another set of transcription factors (Oct3/4, SOX2, Nanog, Lin28) into human fibroblasts [19, 20].”
BackgroundThe ground state of embryonic stem cell self-renewal
Ying, Q.-L., Wray, J., Nichols, J., Batlle-Morera, L., Doble, B., Woodgett, J., Cohen, P., & Smith, A. (2008) · Nature · doi:10.1038/nature06968 · Cited by 3,442 · cited 1×
“Mouse ES cells have been reported to be maintained by adding a GSK3β inhibitor which promotes WNT/β-catenin signaling and a MEK inhibitor to block the FGF/ERK pathway [60].”
BackgroundWarren, L., Manos, P. D., Ahfeldt, T., Loh, Y.-H., Li, H., Lau, F., Ebina, W., Mandal, P. K., Smith, Z. D., Meissner, A., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.012 · Cited by 2,662 · cited 1×
“The repeated administration of synthetic modified messenger RNA has recently been reported to be able to reprogram the human somatic cells into iPS cells with a high efficiency [41] (Fig.”
BackgroundGeneration of Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming Proteins
Kim, D., Kim, C.-H., Moon, J.-I., Chung, Y.-G., Chang, M.-Y., Han, B.-S., Ko, S., Yang, E., Cha, K. Y., Lanza, R., et al. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.05.005 · Cited by 1,814
Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins
Zhou, H., Wu, S., Joo, J. Y., Zhu, S., Han, D. W., Lin, T., Trauger, S., Bien, G., Yao, S., Zhu, Y., et al. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.04.005 · Cited by 1,788
Maherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R., et al. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.05.014 · Cited by 1,725 · cited 1×
“while also showing germline transmission [16–18].”
Induced pluripotent stem cells generated without viral integration
Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G., & Hochedlinger, K. (2008) · Science · doi:10.1126/science.1162494 · Cited by 1,683
Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes
Aasen, T., Raya, A., Barrero, M. J., Garreta, E., Consiglio, A., Gonzalez, F., Vassena, R., Bilić, J., Pekarik, V., Tiscornia, G., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt.1503 · Cited by 1,423 · cited 1×
“Human iPS cells have been reported to be established from skin fibroblasts [19-21], keratinocytes[22], and mobilized CD34+ hematopoietic stem/progenitor cells [23], and differentiated T cells from peripheral blood [24-26].”
BackgroundFUSAKI, N., BAN, H., NISHIYAMA, A., SAEKI, K., & HASEGAWA, M. (2009) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.85.348 · Cited by 1,411 · cited 1×
“iPSCs can now be established by the transduction of the reprogramming factors with adenoviruses, sendaiviruses, plasmid vectors, and removable transposon systems [33-38].”
BackgroundHuman cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population
Yang, L., Soonpaa, M. H., Adler, E. D., Roepke, T. K., Kattman, S. J., Kennedy, M., Henckaerts, E., Bonham, K., Abbott, G. W., Linden, R. M., et al. (2008) · Nature · doi:10.1038/nature06894 · Cited by 1,389
Cited by
Mending broken hearts: cardiac development as a basis for adult heart regeneration and repair
Xin, M., Olson, E. N., & Bassel-Duby, R. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3619 · Cited by 514
Kawamura, M., Miyagawa, S., Miki, K., Saito, A., Fukushima, S., Higuchi, T., Kawamura, T., Kuratani, T., Daimon, T., Shimizu, T., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.084343 · Cited by 495
Guo, L., Abrams, R. M. C., Babiarz, J. E., Cohen, J. D., Kameoka, S., Sanders, M. J., Chiao, E., & Kolaja, K. L. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr158 · Cited by 272
Kawamura, M., Miyagawa, S., Fukushima, S., Saito, A., Miki, K., Ito, E., Sougawa, N., Kawamura, T., Daimon, T., Shimizu, T., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.000366 · Cited by 199
“hiPS cell carries a capacity of unlimited proliferation and differentiation to cardiomyocyte.(7) Transplantation of hiPS-derived cardiomyocytes (hiPS-CMs) would have, thus, a potential to Background—Transplantation of cardiomyocytes that are derived from human induced pluripotent stem cell–derived cardiomyocytes (hiPS…”
BackgroundHayakawa, T., Kunihiro, T., Ando, T., Kobayashi, S., Matsui, E., Yada, H., Kanda, Y., Kurokawa, J., & Furukawa, T. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.09.010 · Cited by 198
“Introduction Human-induced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs) and human embryonic stem cell-derived cardiomyocyte (hES-CMs) hold promise for the applications in cardiac cell biology [1], drug development [2–6] and cardiac therapeutics [7–11].”
BackgroundYoshida, S., Miyagawa, S., Fukushima, S., Kawamura, T., Kashiyama, N., Ohashi, F., Toyofuku, T., Toda, K., & Sawa, Y. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.08.012 · Cited by 178
Kawamura, T., Miyagawa, S., Fukushima, S., Maeda, A., Kashiyama, N., Kawamura, A., Miki, K., Okita, K., Yoshida, Y., Shiina, T., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.01.012 · Cited by 145
“Thus, transplantation with induced pluripotent stem cells (iPSCs) represents a promising treatment for this condition (Yoshida and Yamanaka, 2010, 2011); accordingly, various studies have examined the potential application of iPSCs for cell transplantation therapy in the heart (Higuchi et al.,…”
BackgroundSelf-citationSugiura, T., Hibino, N., Breuer, C. K., & Shinoka, T. (2016) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-016-0559-z · Cited by 53
“Human iPS cells represent an unlimited source of cardiomyocytes because of their great potential for differentiation and are therefore one of the most promising sources of cells for cardiac regeneration therapy [7, 8].”
Background
Metadata
- Authors
- Yoshida, Y., & Yamanaka, S.
- Venue
- Journal of Molecular and Cellular Cardiology
- Publisher
- Elsevier BV
- Published
- 2011-02
- Volume
- 50
- Issue
- 2
- Pages
- 327-332
- ISSN
- 0022-2828 (ISSN-L)
- OpenAlex
- W2030258556
- Cited by
- 171
- References
- 20
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.